Oculus secures U.S. patent for skin ulcer technology

12/28/2012 | MedCityNews.com

Oculus Innovative Sciences has received a U.S. patent for its Microcyn Technology to be used in treating patients with skin ulcers. The technology is administered to skin ulcers either by irrigation, soaking and washing, or by applying a wound dressing that has been soaked with the technology.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA